Clinical research studies have found that the prognostic ratio of the ALDH1 gene family can be used as a robust poor predictor of various solid cancers, including breast cancer, colon cancer, esophageal squamous cell carcinoma, non-small cell lung cancer, ovarian cancer, and other cancers (18, 19). This evidence concerns the gene ALDH1A1 and ovarian cancer.